{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-051549","form_type":"8-K","ticker":"BTSG","cik":"0001865782","company_name":"BrightSpring Health Services, Inc.","filed_at":"2024-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.977079+00:00","generated_at":"2026-06-03T00:54:33.158916+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"BrightSpring Q1 revenue up 27%, net loss $46M; raises FY 2024 guidance","bullets":["Net revenue of $2.577B, up 27% YoY; adjusted EBITDA $131M, up 13.2%.","Pharmacy Solutions revenue $1.977B (+35%); Provider Services revenue $600M (+7%).","Net loss of $46M, widened from $22M loss in Q1 2023.","Raised FY 2024 guidance: revenue $10.3-10.8B, Adj. EBITDA $555-570M (excl. QIP).","Appointed Olivia Kirtley and Timothy Wicks (ex-Optum EVP) to Board of Directors."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-051549","json":"https://secwatch.observer/filing/0000950170-24-051549.json","markdown":"https://secwatch.observer/filing/0000950170-24-051549.md","text":"https://secwatch.observer/filing/0000950170-24-051549.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1865782/000095017024051549/0000950170-24-051549-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1865782/000095017024051549/btsg-20240502.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T00:54:33.158916+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1ed48254812fd4b2cf0affc1c9b5e6761fd91e1d","claim":"BrightSpring Health Services, Inc. reported first quarter ended March 31, 2024 results: revenue $2,577 million, net income Net loss of $46 million. Guidance raised.","evidence_excerpt":"today announced financial results for the first quarter ended March 31, 2024, and increases 2024 revenue and Adjusted EBITDA 1 guidance. Financial Highlights • Net Revenue of $2,577 million, up 27.0% compared to $2,028 million in the first quarter of 2023. • Net loss of $46 million, compared to net loss of $22 million in the first quarter of 2023. • Adjusted EBITDA","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1865782/000095017024051549/0000950170-24-051549-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Revenue","value":"$2,577 million"},{"label":"Net income","value":"Net loss of $46 million"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}